24 Jul 2020 --- A two-year partnership between DuPont Nutrition & Biosciences (N&B) and US-based Rutgers University is set to research regulating gut bacteria and decreasing chemotherapy side effects. The microbiome plays an essential role in the oral ingestion of oncology drugs that can cause inflammation of the digestive tract. Regulating beneficial microbes in the gut could, therefore, lead to improving patient care and comfort for those undergoing cancer treatment, the university highlights.
